May 2021 - Trinidad Capital Partners (“Trinidad”) arranged a USD linked private placement for a biotech company.
While the note is issued in local currency, it is priced like a comparable USD instrument in exchange for FX protection to the investor. In essence, this product gives the issuer the opportunity to trade a hedge naturally offered by its export business against lower cost of financing.
In addition to arranging the structured note, Trinidad acts as advisor to both the investor and the issuer.
Trinidad is an emerging market debt and debt capital market focused investment advisor. Trinidad currently advises institutional investors from developed and emerging markets, large and midsize companies and families and provides origination, structuring, loans administration and workout services. For further information, please visit www.trinidadcp.com
For more information on this transaction, please contact:
Tel: +54 9 11 4577 5924
Tel: +1 646 371 26 77